Biocat

Biocat

Berlin, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

BioCat is a well-established, privately-held distributor of life science research tools and reagents based in Heidelberg, Germany. Operating for over two decades, it has built a comprehensive portfolio of products from global suppliers, focusing on genomics, proteomics, and cell biology. The company leverages its strategic location in the Heidelberg Technology Park and strong supplier relationships to provide cutting-edge solutions and responsive service to the European research market. Its business model is based on distribution and partnership, positioning it as a service-oriented enabler of scientific research rather than a primary developer of therapeutics or diagnostics.

DiagnosticsAntibodies

Technology Platform

Curated distribution network and integrated service model for life science research tools in genomics, proteomics, and cell biology.

Opportunities

The growing European life science research tools market and BioCat's strategic location in the Heidelberg research cluster provide a steady demand base.
An additional opportunity lies in forming new distribution partnerships with innovative manufacturers seeking access to the German and European markets.

Risk Factors

BioCat faces intense competition from large global distributors and relies entirely on third-party suppliers, creating dependency risks.
Its revenue is also vulnerable to fluctuations in public and private research funding within its core European markets.

Competitive Landscape

BioCat operates in the highly competitive life science distribution sector, competing against multinational giants like Thermo Fisher Scientific and Merck KGaA, as well as other regional distributors. Its differentiation is based on specialized customer service, technical support, and agility in a focused geographic and product niche.